Mylan N.V. (NASDAQ:MYL) marched up 15.03% compared to a 52-week low price of $16.63. The shares were last seen trading -2.5% lower, taking the closing price at $19.13 on 7/10/2019. At a recent session, the prices were hovering between $18.55 and $19.1911. This company shares are 54.36% off its target price of $29.53 and the current market capitalization stands at $9.82B. The recent change has given its price a -3.85% deficit over SMA 50 and -51.68% deficit over its 52-week high. The stock witnessed 8.88% gains, -29.46% declines and -35.96% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found MYL’s volatility during a week at 2.98% and during a month it has been found around 3.03%.

What Does Mylan N.V. (MYL) Do?

The company describes itself in regulatory filings as, “Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.” [Text can be found here: under company description.]

Mylan N.V. (MYL) Top Holders

Institutional investors currently hold around $8.64 billion or 88.3% in MYL stock. Look at its top three institutional owners: Wellington Management Group Llp owns $955.13 million in Mylan N.V., which represents roughly 9.73% of the company’s market cap and approximately 11.05% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 47,022,160 shares of the stock are valued at $922.58 million. The third largest holder is Blackrock Inc., which currently holds $785.18 million worth of this stock and that ownership represents nearly 8% of its market capitalization.

Mylan N.V. 13F Filings

At the end of March reporting period, 244 institutional holders increased their position in Mylan N.V. (NASDAQ:MYL) by some 43,219,758 shares, 231 decreased positions by 35,245,991 and 81 held positions by 362,018,980. That puts total institutional holdings at 440,484,729 shares, according to SEC filings. The stock grabbed 50 new institutional investments totaling 2,973,530 shares while 73 institutional investors sold out their entire positions totaling 9,240,044 shares.

Mylan N.V. (NASDAQ:MYL) Insider Trades

Multiple company employees have indulged in significant insider trading. Mylan N.V. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Campbell Paul has sold 11,533 shares of Mylan N.V. (MYL) in the trading session dated Mar. 04, 2019. These shares are worth $317,158 and were traded at $27.5 each. The SEC filing shows that Campbell Paul performed a sale of 7,030 shares. The disposed these shares by way of transaction on Mar. 06, 2018. The company’s shares were given away at $44.01 per share worth to an income of some $309,390 to the account of Campbell Paul.

Director, COURY ROBERT J, sold 200,000 common shares of Mylan N.V. (MYL) in the open market. In a transaction dated Mar. 06, 2018, the shares were put up for sale at an average price of $40.93, raking in a sum of $8,186,000. After this sale, 995,164 common shares of MYL are directly owned by the insider, with total stake valued at $19,037,487.

In the transaction dated Mar. 02, 2018, a great number of shares sold came courtesy the Chief Commercial Officer; Mauro Anthony disposed a total of 12,257 shares at an average price of $40.35, amounting to approximately $494,570. The insider now directly owns 153,258 shares worth $2,931,826.

Mylan N.V. (MYL) Analyst Guide

Several analysts have released their opinion on Mylan N.V. (NASDAQ:MYL), with 5 analysts believing it is a strong buy. Whereas 6 of them predict the stock is a hold. Also, there are 8 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.05 average brokerage recommendation [T1].